SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-012595
Filing Date
2022-03-30
Accepted
2022-03-30 16:03:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A sndx-defa14a_20220511.htm DEFA14A 15460
2 GRAPHIC gif4yzjuz2x0000002.jpg GRAPHIC 381418
3 GRAPHIC gif4yzjuz2x0000001.jpg GRAPHIC 649845
  Complete submission text file 0001564590-22-012595.txt   1436669
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37708 | Film No.: 22786380
SIC: 2834 Pharmaceutical Preparations